ORG-201745
| Clinical data | |
|---|---|
| Drug class | Progestin; Progestogen |
| Identifiers | |
| CAS Number | |
| PubChem SID | |
ORG-201745 is a progestin which was originated by Organon and was under development by Schering-Plough (which acquired Organon in 2007) for the treatment of "female genital diseases" and as a hormonal contraceptive for the prevention of pregnancy but was never marketed.[1]
References
- ↑ "ORG 201745 - AdisInsight". adisinsight.springer.com.
Categories:
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Short description is different from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All stub articles
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.